Loading...
Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results—A Retrospective, Comparative Study
PURPOSE: To compare one-year treatment outcomes of intravitreal aflibercept (IVA) and intravitreal ranibizumab (IVR) for treatment of myopic choroidal neovascularization (mCNV). METHODS: The medical records of a total of 30 eyes diagnosed with mCNV and underwent IVA or IVR treatment for a minimum on...
Na minha lista:
| Udgivet i: | J Ophthalmol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7012232/ https://ncbi.nlm.nih.gov/pubmed/32082619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8639243 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|